Editorial  by Toouli, Jim
EDITORIAL
Critical Appraisal of a Manuscript
When asked to review a manuscript, I usually go to
the title first and then the abstract to obtain an overall
feel for the topic. Then I proceed to read the body of
the manuscript in order to critically appraise it. I wish
to be fair in my appraisal and not be governed by my
own bias’ regarding the topic. Consequently, I have
developed over the years a structured approach to
critically appraising a manuscript using geometrical
designs to assist me.
In a series of editorials over the next few issues of
HPB, I am going to share with the readers a way of
critically appraising a manuscript or a study using the
geometrical approach. This approach has been devel-
oped following reading and suggestions from a variety
of notable authors who have written extensively on
this topic. I reference some of these publications at the
end of this initial editorial.
The crux of the geometrical approach is based on
subdividing the study into three major components as
illustrated by a triangle, a circle and square (Figure 1).
This is called the PECOT Diagram. Each of the
letters being representative of the components of a
typical clinical study.
PECOT
Using the geometrical design as an aid a clinical study
may be subdivided into the following components.
Population: Within the triangle should be placed
the population being studied. Any clinical study has a
group of subjects who are representative of the
population at large, having the condition which is
being studied. Consequently, thoughts and criticisms
regarding the population being studied can be
grouped within the triangle, thus helping the reviewer
focus the criticism on the population selected.
Intervention and Comparison: Within the circle the
intervention or exposure against a comparison is
categorised. There may be more than one exposure
or there may just be one that is compared against a
control or another exposure. The circle is subdivided
in a manner which illustrates what is being done and
what it is compared against.
Outcomes: The results of the exposure or exposures
against the comparison are then recorded in the
square which is designed to illustrate positive or
negative outcomes as a result of the exposure, when
compared with the comparison. There may just be a
single outcome, or there may be a number of out-
comes which can be categorised in a linear fashion
against the exposure and the comparison.
Time: Finally the last component of the PECOT
diagram is the time component which needs to be
specified. In other words, is the study confined to
events that are analysed at one point in time after the
exposure and comparison? Or is it a continual change
which is being accessed over a longer period of time?
Study Validity
Having defined all of the components of the PECOT
diagram, it is now time to revisit each one of these to
assess whether the components are well designed (i.e.
in other words, are absent of bias). Bias (or systematic
error) is one of the major bugbears of clinical studies.
It is extremely difficult to remove bias from clinical
studies, however it is important to be able to define
the level of bias so that the results and ultimately the
conclusions that we draw from any study can be
evaluated in the context of this knowledge.
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Figure 1. PECOT diagram: design components.
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I refer you back to the PECOT diagram in order to
appraise any manuscript in order to determine the
degree if any of bias.
Selection Bias: Look to the triangle which defines
the study population. Now ask the question whether
the population being studied truly represents the
general population with the condition which is being
studied. Is the study population representative of the
source population? For instance, if we were to study
Gallstone Disease then to represent the population at
large we would need to go out into the community to
select our study population. If we were to make our
selection only from patients who presented to a
hospital we would be biasing our selection. Of course
there is nothing wrong with basing a study on
Gallstone Disease only on a population that presents
to a hospital. However, the conclusions that we would
draw from such a selection can only refer to that
population and not to the general population in the
community. Consequently, in critically appraising a
manuscript do ask the question whether the popula-
tion that has been selected is truly representative of
what the researchers aim to study.
Confounder: Confounding bias occurs at the next
geometric component (i.e. the circle). The confoun-
der is another type of treatment which might influence
the exposure and/or the comparison. There is a
famous study which was conducted on post meno-
pausal women placed on hormone replacement ther-
apy. It was noted in a cohort study of women on
hormone replacement therapy that the prevalence of
heart attacks was lower when compared with the
general population of post menopausal women not
placed on hormone replacement therapy. However,
on closer analysis of the population being studied it
was also noted that women who had been placed on
hormone replacement therapy were also the type of
women who tended to have healthier lifestyles, would
be of normal weight and would include physical
exercise as part of their daily routine. When this
component or this confounder was removed from the
equation, it was noted that hormone replacement
therapy had little or no effect on the prevalence of
subsequent heart attack in the population of post
menopausal women.
The way that we remove confounders in a clinical
study is to prospectively randomise the population
that is being studied. This is why prospective rando-
mised studies are thought of so highly in the medical/
clinical literature. When done appropriately, it is the
most powerful means of removing confounders which
may influence the results of the treatment being tried.
A number of other confounders may arise and it is
important when reviewing a manuscript to look for
these or at least ask the question which to an
experienced clinician an obvious answer may exist.
Have there been any other interventions in any of the
groups?
Measurement Bias: This occurs in both the circle
and the square of outcomes. It is important when
critically appraising a manuscript to ensure that there
has not been any bias in the measurement of the
exposures, the comparisons or any of the outcomes. In
other words the numbers need to add up and be
consistent with what was intended on the outset. If
the numbers do not add up then it is necessary for the
investigators to have accounted for the differences.
Such differences in the numbers might be produced if
individuals have been lost in follow up or if unex-
pected deaths have occurred etc. A good study will
account for every individual entered into the study.
Measurement Bias may also occur by what is
known as compliance or contamination of the num-
bers. This is where patients who were intended to
have one type of intervention as opposed to another
receive the wrong intervention. Consequently, the
numbers are contaminated by this fault in the study.
As can be seen from the above I have to at this stage
not used any numbers, formulae or statistics. What I
have done is use the geometrical designs illustrated in
the figure to subdivide any study according to its
components. The PECOT diagram is a geometrical
way of doing this and assists me in critically appraising
any study.
In subsequent issues of the Journal, I will use the
editorial pages to talk about the use of numbers, what
they mean to a clinician and how one can use this type
of approach to not only critically appraise a manu-
script for a journal such as HPB, but to also teach our
colleagues and students.
Jim Toouli
Editor-in-Chief
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